TrialJAMA network open2019

Efficacy and Safety of Gemcitabine With Trastuzumab and Pertuzumab After Prior Pertuzumab-Based Therapy Among Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Phase 2 Clinical Trial.

Neil M Iyengar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.